Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Longitudinal Biomarkers in Lung Injury

NCT04747782 is registered in ClinicalTrials.gov with Dr. Andrew Baker as lead sponsor.

NCT NCT04747782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04747782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Longitudinal Biomarkers in Lung Injury
Lead sponsor
Dr. Andrew Baker
Phase
Observational
Overall status
Unknown status
Start date
March 23, 2020
Completion date
December 31, 2021
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, critical illness, respiratory disease